Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 4/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.31 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2944692 | 0.92 | THRB (0.44) | TSHRTHRBALDH1A1PGK1PGK2 | |
| SCHEMBL541439 | 0.92 | TSHR (0.42) | TSHRTHRBALDH1A1PGK1PGK2 | |
| SCHEMBL541226 | 0.91 | TSHR (0.44) | TSHRTHRBALDH1A1ENPP2LPAR6 | |
| SCHEMBL2038860 | 0.90 | THRB (0.39) | TSHRTHRBALDH1A1LPAR1LPAR2 | |
| SCHEMBL541451 | 0.89 | TSHR (0.47) | TSHRTHRBENPP2LPAR6LPAR1 | |
| SCHEMBL6851650 | 0.89 | TSHR (0.38) | TSHRTHRBALDH1A1 | |
| SCHEMBL20582579 | 0.86 | THRB (0.40) | TSHRTHRBALDH1A1PGK1PGK2 | |
| SCHEMBL16737919 | 0.86 | TSHR (0.39) | TSHRTHRBALDH1A1LPAR1LPAR2 | |
| SCHEMBL28637235 | 0.84 | TSHR (0.40) | TSHRTHRBENPP2LPAR6LPAR1 | |
| SCHEMBL3677974 | 0.83 | TSHR (0.42) | TSHRTHRBALDH1A1LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189121-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2024-06-13 | — | — | US | claimed |
| EP-3666299-B1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2024-05-15 | — | — | EP | claimed |
| US-11903850-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2024-02-20 | — | — | US | claimed |
| WO-2023021885-A1 | ELECTROLYTIC SOLUTION FOR CAPACITOR AND CAPACITOR | カーリットホールディングス株式会社 | 2023-02-23 | — | — | WO | claimed |
| WO-2023013368-A1 | METHOD FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR | カーリットホールディングス株式会社 | 2023-02-09 | — | — | WO | claimed |
| US-20230036800-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2023-02-02 | — | — | US | claimed |
| US-11406514-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-08-09 | — | — | US | claimed |
| US-20220227954-A1 | POLYMERIC SURFACE HAVING REDUCED BIOMOLECULE ADHESION TO THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | OAKTREE FUND ADMINISTRATION, LLC | 2022-07-21 | — | — | US | claimed |
| US-11369497-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-06-28 | — | — | US | claimed |
| EP-3862384-A2 | POLYMERIC SUBSTRATE WITH A SURFACE HAVING REDUCED BIOMOLECULE ADHESION, AND THERMOPLASTIC ARTICLES OF SUCH SUBSTRATE | SiO2 Medical Products, Inc. (US) | 2021-08-11 | — | — | EP | claimed |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2010-08-12 | — | — | US | claimed |
| EP-2205197-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'Oreal (FR) | 2010-07-14 | — | — | EP | claimed |
| US-20100094339-A1 | COATING COMPOSITIONS | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |
| US-20090304770-A1 | POLYMER | BIOCOMPATIBLES UK LIMITED (GB) | 2009-12-10 | — | — | US | claimed |
| EP-2120824-A1 | COATING COMPOSITIONS | Tyco Healthcare Group LP (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2009056545-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | L'OREAL (FR) | 2009-05-07 | — | — | WO | claimed |
| WO-2008143654-A1 | COATING COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |
| EP-1764078-B1 | Microcapsules with aqueous core and their use in cosmetic compositions | OREAL (FR) | 2008-05-14 | — | — | EP | claimed |
| EP-1764078-A1 | Microcapsules with aqueous core and their use in cosmetic compositions | L'OREAL (FR) | 2007-03-21 | — | — | EP | claimed |
| US-6828028-B1 | Having surface treated with copolymer of such as ring opened glycidyl methacrylate and 2-(methacryloyloxy)ethyl-2-(tri-methylammonio)ethylphosphate; lubricity, blood compatible, safe, stable, durable | NOF CORPORATION (JP) | 2004-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304770-A1 | POLYMER | MLX, BMX, PUF60 | TSHR 2143/4885THRB 704/4885ALDH1A1 3167/4885 |
| US-20100203004-A1 | COSMETIC COMPOSITION CONTAINING A TENSIONING AGENT AND AN ACRYLIC POLYMER | PHOSPHO1, CUTA, SGMS1 | TSHR 3000/4885THRB 3607/4885ALDH1A1 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.